Virtual FD, So Much More Than Compliance

Oxford Drug Design is an advanced spinout from Oxford University. They are an innovative biotechnology company discovering and developing novel therapeutics supported by pioneering computational methods.

Alan D. Roth

Here’s what Alan D. Roth, their CEO said about working with Tracy as their Virtual FD:

“As the CEO of Oxford Drug Design, Tracy has impressed me in her capacity as Finance Director for the business.

She is a finance professional who adds so much more than just the compliance activities you would typically expect for an FD in a small business. Of course she brings robust financial control, and has demonstrated this by improving our approval processes to ensure that our spend and investments are in line with our plans. She also keeps a close eye on the detail of our finances and our financial projections, giving me the confidence to focus on the strategic direction of the business.

In addition, Tracy brings many years of commercial experience to our leadership group. This adds another dimension to her skillset. She understand our business model well, and regularly brings a new perspective, and valued new ideas or approaches for the team to consider.”

Tracy said:

“I personally get a great deal of satisfaction from providing financial leadership and support to Alan and the management team at Oxford Drug Design. It’s lovely to receive such praise.”

Tracy has built up experience of supporting growth for scale-up businesses, especially in tech, pharma and science.